Let’s revelationize science, together

Tackling treatment gaps takes new thinking. It also takes collaboration. At Aclaris, we’re always looking to partner with those who share our passion for helping patients with underserved skin and hair conditions.

Business development partnerships

We are open to discussing proposals for business development partnerships that align with our vision. Areas of particular interest to us include:

  • In-license innovative commercial-stage or development-stage medical or aesthetic dermatology treatments
  • Out-license rights to our investigational protein kinase inhibitors for non-dermatology indications
  • Out-license commercial rights outside of the United States to treatments for seborrheic keratoses and common warts


We are actively seeking research and licensing partners to fully leverage the transformational potential of our KINectTM Platform for drug discovery. Specific areas of interest include:

  • Kinase inhibitors for autoimmune diseases, such as rheumatoid arthritis, diseases of chronic inflammation, such as COPD, and cancer, particularly breast, colon, and pancreatic cancer
  • New therapeutic applications of our cysteinome-targeted chemical library representing 60% of the kinome

Learn more about the KINectTM platform

If you wish to inquire about investigator-initiated studies, find out more.